{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:28:52Z","timestamp":1793500132737,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jchf.2025.102688","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:49:17Z","timestamp":1759549757000},"page":"102688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sodium-Glucose Cotransporter 2 Inhibitors After Preeclampsia"],"prefix":"10.1016","volume":"13","author":[{"given":"Rossana","family":"Orabona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-3454","authenticated-orcid":false,"given":"Edoardo","family":"Sciatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Prefumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.A.","family":"Spaanderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-7882","authenticated-orcid":false,"given":"Michele","family":"Senni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-9140","authenticated-orcid":false,"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chahinda","family":"Ghossein-Doha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2025.102688_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/OGX.0000000000000846","article-title":"The impact of preeclampsia on women's health: cardiovascular long-term implications","volume":"75","author":"Orabona","year":"2020","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jchf.2025.102688_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ejhf.3520","article-title":"Hypertensive pregnancy disorder, an under-recognized women specific risk factor for heart failure?","volume":"27","author":"Ghossein-Doha","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102688_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: A State-of-the-Art Review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jchf.2025.102688_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","article-title":"Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: from the EMPA-TROPISM study","volume":"9","author":"Requena-Ib\u00e1\u00f1ez","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102688_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ejhf.3129","article-title":"The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: systematic review and meta-analysis","volume":"26","author":"Usman","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102688_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.826792","article-title":"Empagliflozin ameliorates preeclampsia and reduces postpartum susceptibility to adriamycin in a mouse model induced by angiotensin receptor agonistic autoantibodies","volume":"13","author":"Zhai","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jchf.2025.102688_bib7","article-title":"A randomized trial of dapagliflozin and metformin, alone and combined, in overweight women after gestational diabetes mellitus","volume":"2","author":"Elkind-Hirsch","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jchf.2025.102688_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jchf.2025.102688_bib9","first-page":"303","article-title":"Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib","volume":"63","author":"Gr\u00fcnert","year":"2022","journal-title":"JIMD Rep"},{"key":"10.1016\/j.jchf.2025.102688_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00592-018-1134-y","article-title":"Empagliflozin, metformin and insulin degludec, during pregnancy: a case report","volume":"55","author":"Formoso","year":"2018","journal-title":"Acta Diabetol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925006183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925006183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:29:51Z","timestamp":1793496591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925006183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213177925006183"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102688","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-Glucose Cotransporter 2 Inhibitors After Preeclampsia","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"102688"}}